Biotech · Private company · Boston, MA, US
Matregenix
Track this companyFree. Adds Matregenix to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Sustained 9-cis Retinoic Acid-Eluting Nanofiber Scaffolds for Enhanced Lymphatic Regeneration and Lymphedema TreatmentFiscal year 2026 · $314.2KNIH RePORTER 1R41HL184685-01A1 · fetched Nov 12, 2026
- Enhancing Dental and Craniomaxillofacial Surgery Outcomes with Cost-Effective and Scalable Animal-Free Amino Acid-Based Membranes for Guided Bone RegenerationFiscal year 2026 · $1.1MNIH RePORTER 5R44DE035026-02 · fetched Nov 12, 2026
- Enhancing Dental and Craniomaxillofacial Surgery Outcomes with Cost-Effective and Scalable Animal-Free Amino Acid-Based Membranes for Guided Bone RegenerationFiscal year 2025 · $976KNIH RePORTER 1R44DE035026-01 · fetched Nov 12, 2026